1. Home
  2. ARLO vs ANAB Comparison

ARLO vs ANAB Comparison

Compare ARLO & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

HOLD

Current Price

$13.25

Market Cap

1.4B

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$47.92

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARLO
ANAB
Founded
2018
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
ARLO
ANAB
Price
$13.25
$47.92
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
$24.00
$60.18
AVG Volume (30 Days)
995.6K
482.0K
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$509,572,000.00
$169,467,000.00
Revenue This Year
$4.76
$135.51
Revenue Next Year
$7.31
N/A
P/E Ratio
$379.51
N/A
Revenue Growth
N/A
196.42
52 Week Low
$7.84
$12.21
52 Week High
$19.94
$52.47

Technical Indicators

Market Signals
Indicator
ARLO
ANAB
Relative Strength Index (RSI) 42.84 55.71
Support Level $13.00 $44.25
Resistance Level $14.26 $48.53
Average True Range (ATR) 0.49 3.02
MACD -0.02 -0.13
Stochastic Oscillator 19.84 70.35

Price Performance

Historical Comparison
ARLO
ANAB

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: